Regal Assets Analytics

SAVA

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-10-20T14:21:50-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , , , , , , , , |

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

Read More
 0

Avadel Shares Stable After Nice Run; Cassava Shares Languish on Alzheimer’s Blues

By |2020-05-21T14:33:03-04:00May 18th, 2020|Categories: Bill Langbein, Insights, SanaCurrents Updates|Tags: , |

Avadel Pharmaceuticals plc (NASDAQ:AVDL) recently announced positive phase III trial [...]

Read More
 0

Cassava Sciences (SAVA) Probability Sentiment

By |2020-04-19T10:24:06-04:00March 7th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Cassava Sciences, Inc. (NASDAQ:SAVA) Probability Sentiment [...]

Read More
 0